VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Auckland International Airport Limited vs Bristol-Myers Squibb Company
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Auckland International Airport Limited
AIA · NZX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Auckland International Airport Limited's moat claims, evidence, and risks.
View AIA analysisBristol-Myers Squibb Company
BMY · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Bristol-Myers Squibb Company's moat claims, evidence, and risks.
View BMY analysisComparison highlights
- Moat score gap: Auckland International Airport Limited leads (74 / 100 vs 56 / 100 for Bristol-Myers Squibb Company).
- Segment focus: Auckland International Airport Limited has 3 segments; Bristol-Myers Squibb Company has 5 segments (27.6% in Eliquis franchise (apixaban)).
- Primary market structure: Monopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Auckland International Airport Limited has 5 moat types across 3 domains; Bristol-Myers Squibb Company has 4 across 3.
Primary market context
Auckland International Airport Limited
Aeronautical (regulated airport services)
Aeronautical airport services at Auckland Airport (airfield landing/parking, passenger terminal and related charges)
New Zealand (Auckland catchment)
Airlines and aviation operators (direct customers); passengers indirectly
Airport infrastructure operator
Bristol-Myers Squibb Company
Eliquis franchise (apixaban)
Direct oral anticoagulants (DOACs) for stroke prevention in NVAF and treatment/prevention of DVT/PE
Global
Payers, PBMs, hospitals, clinics, pharmacies
Branded drug manufacturer (co-commercialization alliance)
27.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Auckland International Airport Limited strengths
Bristol-Myers Squibb Company strengths
Segment mix
Auckland International Airport Limited segments
Full profile >Aeronautical (regulated airport services)
Monopoly
Retail concessions and car parking
Quasi-Monopoly
Commercial property and precinct development
Competitive
Bristol-Myers Squibb Company segments
Full profile >Eliquis franchise (apixaban)
Oligopoly
Immuno-oncology checkpoint inhibitors (Opdivo/Yervoy/Opdualag)
Oligopoly
Hematology (Revlimid/Pomalyst/Reblozyl)
Competitive
Immunology (Orencia/Sotyktu)
Competitive
Other specialty & emerging products (CAR-T, cardiomyopathy, neuroscience, and mature brands)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.